4//SEC Filing
Yamada Tadataka 4
Accession 0001209191-21-021221
CIK 0001718852other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 9:51 PM ET
Size
7.2 KB
Accession
0001209191-21-021221
Insider Transaction Report
Form 4
Yamada Tadataka
DirectorOther
Transactions
- Conversion
Series B Preferred Stock
2021-03-16−133,334→ 0 total→ Common Stock (13,333 underlying) - Conversion
Common Stock
2021-03-16+13,333→ 13,333 total
Footnotes (1)
- [F1]The shares of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's common Stock, for no additional consideration, at a ratio of ten-for-one share, immediately prior to the consummation of the Issuer's initial public offering.
Documents
Issuer
Prometheus Biosciences, Inc.
CIK 0001718852
Entity typeother
Related Parties
1- filerCIK 0001402530
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 9:51 PM ET
- Size
- 7.2 KB